Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Gastrointestinal Neoplasms 1Esophageal Squamous Cell Carcinoma 1Colorectal Neoplasms, Hereditary Nonpolyposis 1Colorectal Neoplasms 1Colonic Polyps 1Clinical Stage III Gastric Cancer AJCC v8 1Adenocarcinoma Of Esophagus 1

Interventions

Specimen Handling 4Surveys and Questionnaires 2Magnetic Resonance Spectroscopy 2Biopsy 2pembrolizumab 1dehydroftorafur 1atezolizumab 1acetylsalicylic acid lysinate 1Oxaliplatin 1Leucovorin 1Interviews as Topic 1High-Throughput Nucleotide Sequencing 1Health Promotion 1Fluorouracil 1Endoscopy 1Endoscopic Mucosal Resection 1Educational Status 1Diffusion Tensor Imaging 1Diet Therapy 1Data Collection 1Colonoscopy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Colorectal Neoplasms, Hereditary Nonpolyposis × Endoscopic Mucosal Resection × Clear all
NCT05078866 2026-03-03

Cancer Preventive Vaccine Nous-209 for Lynch Syndrome Patients

National Cancer Institute (NCI)

Phase 1/2 Active not recruiting
45 enrolled
Gastrointestinal

Colorectal Neoplasms, Hereditary Nonpolyposis, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡